MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-10-0039489
Auspik Pharmaceuticals Private Limited
Auspik Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹24.19 Cr
▲ 155% YoY
Net profit · FY 2024
₹14.91 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹33.98 Lakh
EBITDA margin 1.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹81.62 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Auspik Pharmaceuticals Private Limited
Data last updated:
Auspik Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2010PTC204055. Its GSTIN is 06AAICA7413N1ZG (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anand Mohan and Lalit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sarover 303 Vasant Housing Complex Mahaveer Nagar Kandivali West, Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.19 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹14.91 Lakh (net margin 0.6%) and EBITDA of ₹33.98 Lakh (EBITDA margin 1.4%). Revenue has declined at a compounded annual rate (CAGR) of 32% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹81.62 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
Auspik Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0039489). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2010PTC204055
Registration Number 204055
Incorporation Date 11 June 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-10-0039489
Key People
Anand Mohan Director Lalit Kumar Director Recognitions & Rankings of Auspik Pharmaceuticals
Contact details
Auspik Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSarover 303 Vasant Housing Complex Mahaveer Nagar Kandivali West, Mumbai, Maharashtra, India – 400067
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Auspik Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Auspik Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Auspik Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Auspik Pharmaceuticals Private Limited, buy the company report.
Financials of Auspik Pharmaceuticals Private Limited
FY 2024 filings availableAuspik Pharmaceuticals Private Limited reported revenue of ₹24.19 Cr (up 155% YoY) for FY 2024.
Revenue · FY 2024
₹24.19 Cr ▲ 155%
Net profit · FY 2024
₹14.91 Lakh margin 0.6%
EBITDA · FY 2024
₹33.98 Lakh margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 155%
3 years · compounded
▲ 32%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 60%
3 years · compounded
▲ 29%
5 years · compounded
▲ 33%
Revenue rose 155% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Auspik Pharmaceuticals Private Limited, buy the company report.
Board of directors of Auspik Pharmaceuticals Private Limited
Auspik Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Mohan | Director | 11 Jun 2010 | 16 Years 5 Months | Current |
| Lalit Kumar | Director | 11 Jun 2010 | 16 Years 5 Months | Current |
Peer comparison
Auspik Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axacus Pharma Private Limited | ₹24.29 Cr (FY 2024) | 37.0% | Ahmedabad, Gujarat, India | |||
| Chemifine Formulations Private Limited | ₹24.25 Cr (FY 2024) | -10.0% | Nellore, Andhra Pradesh, India | |||
| Sunvij Drugs Private Limited | ₹24.23 Cr (FY 2024) | 24.0% | Vadodara, Gujarat, India | |||
| Auspik Pharmaceuticals Private Limitedthis company | ₹24.19 Cr (FY 2024) | ₹14.91 Lakh | 0.6% | 155.0% | Mumbai, Maharashtra, India | |
| Ultra Drugs Formulations Private Limited | ₹24.17 Cr (FY 2024) | 198.0% | Baddi, Himachal Pradesh, India | |||
| Alchemy Medicine Private Limited | ₹24.15 Cr (FY 2025) | 28.0% | New Delhi, Delhi, India |
To see the full peer comparison of Auspik Pharmaceuticals Private Limited, buy the company report.
Auditor
Auspik Pharmaceuticals Private Limited is audited by ANEJA GIRISH & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANEJA GIRISH & ASSOCIATES | FY 2021 | 019483N |
Shareholding
The shareholding of Auspik Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Auspik Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹81.62 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 May 2025 | 101095450 | Hdfc Bank Limited | ₹11.52 Lakh | Open | |
| 26 Nov 2024 | 101019088 | Hdfc Bank Limited | ₹20.1 Lakh | Open | |
| 16 Mar 2011 | 10284683 | J&K Bank Limited | ₹50 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Auspik Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Auspik Pharmaceuticals. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Appeal | Filed by the company against Ms Sri Sai Pharmaceuticals | Disposed |
| District court, Karnal, Haryana | Civil suit | Filed by the company against Ms Sri Sai Pharmaceuticals , | Disposed |
To see the full case history of Auspik Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Auspik Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Auspik Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICA7413N1ZG | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Auspik Pharmaceuticals Private Limited, buy the company report.
Recent activity
Auspik Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Harpreet Kaur ceased to be Director on 01 Sep 2015.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 11.52 Lakh with Charge ID 101095450 was registered on 01 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.10 Lakh with Charge ID 101019088 was registered on 26 Nov 2024.
AGM
Auspik Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Auspik Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Ceased
Harpreet Kaur ceased to be Director.
Ceased
Ranjit Singh ceased to be Director.
Charges
A charge with J&K Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 10284683 was registered on 16 Mar 2011.
Appointed
Anand Mohan was appointed as Director.
Appointed
Lalit Kumar was appointed as Director.
Incorporation
11 Jun 2010
Auspik Pharmaceuticals Private Limited was registered on 11 Jun 2010 with Roc Mumbai I & aged 16 years 5 months as per MCA records.
Frequently asked questions
Auspik Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 June 2010 (16+ years old) and is registered under CIN U74999MH2010PTC204055.
Auspik Pharmaceuticals has 2 current directors:
- Anand Mohan - Director
- Lalit Kumar - Director
The latest financial statements of Auspik Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Auspik Pharmaceuticals is 06AAICA7413N1ZG, registered in Haryana.
The CIN (Corporate Identification Number) of Auspik Pharmaceuticals is U74999MH2010PTC204055. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Auspik Pharmaceuticals has 2 court cases on record: 2 filed by the company.
Auspik Pharmaceuticals was incorporated on 11 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Auspik Pharmaceuticals by revenue are Axacus Pharma Private Limited, Chemifine Formulations Private Limited, Sunvij Drugs Private Limited, Ultra Drugs Formulations Private Limited, Alchemy Medicine Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harpreet Kaur ceased to be Director on 01 Sep 2015. Ranjit Singh ceased to be Director on 01 Sep 2015. Anand Mohan was appointed as Director on 11 Jun 2010. Auspik Pharmaceuticals has 4 board changes on record in total.
Yes, Auspik Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-10-0039489).
The registered office of Auspik Pharmaceuticals is at Sarover 303 Vasant Housing Complex Mahaveer Nagar Kandivali West, Mumbai, Maharashtra, India – 400067.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages